Clinical Trials
7 trialsNCT00070382 2020-08-03
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
Jonsson Comprehensive Cancer Center
Phase 3 Completed
NCT00416624 2017-02-10
Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
Mayo Clinic
Phase 2 Completed
NCT00230321 2013-02-04
A Study of Darbepoetin Alfa in Patients With Myelodysplastic Syndrome (MDS)
Stanford University
Phase 1/2 Completed
NCT01222195 2012-08-07
Lenalidomide and Darbepoetin in Low-Intermediate Risk Myelodysplastic Syndrome (MDS)
M.D. Anderson Cancer Center
Phase 2 Terminated
NCT00661999 2011-05-17
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
Mayo Clinic
Phase 3 Completed
NCT00557817 2010-01-11
Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)
University of Liege
Phase 2/3 Completed
NCT00355407 2009-03-13
Darbepoetin Alfa (Aranesp) Following Allogeneic Stem Cell Transplantation
Dana-Farber Cancer Institute
Phase NA Completed